Johnson & Johnson (JNJ) Retained Earnings (2009 - 2026)

Johnson & Johnson (JNJ) posted Retained Earnings of -$14.8 billion for Q1 2026, down 108.78% sequentially from $169.0 billion in Q4 2025, and down 109.12% YoY from $162.6 billion in Q1 2025.

Johnson & Johnson (JNJ) Retained Earnings (2009 - 2026) Analysis & Trends

Johnson & Johnson (JNJ) has 18 years of Retained Earnings data on file, last reported at -$14.8 billion in Q1 2026.

  • Quarterly Retained Earnings fell 109.12% year-over-year to -$14.8 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$14.8 billion (down 109.12% YoY) and the FY2025 annual result came in at $169.0 billion, up 8.46% from the prior year.
  • Retained Earnings eased to -$14.8 billion in Q1 2026 per JNJ's latest filing, from $169.0 billion in the prior quarter.
  • The five-year high for Retained Earnings was $169.0 billion in Q4 2025, with the low at -$15.3 billion in Q4 2022.
  • Average Retained Earnings over 5 years is $65.4 billion, with a median of $56.6 billion recorded in 2022.
  • Year-over-year, Retained Earnings sank 111.52% in 2022 and jumped 1343.64% in 2024.
  • Johnson & Johnson's Retained Earnings stood at -$15.3 billion in 2022, then advanced by 18.08% to -$12.5 billion in 2023, then jumped by 1343.64% to $155.8 billion in 2024, then increased by 8.46% to $169.0 billion in 2025, then tumbled by 108.78% to -$14.8 billion in 2026.
  • Business Quant data shows JNJ's Retained Earnings at -$14.8 billion in Q1 2026, $169.0 billion in Q4 2025, and -$15.2 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 29.51 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn -14.83 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn -17.87 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 9.67 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 66.72 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn -190.00 Mn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 78.00 Mn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn -7.20 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Biogen 30.87 Bn 26.59 Bn 1.82 Bn -140.20 Mn

Historic Data

Download Data
DateValue
Mar 29, 2026 -14.83 Bn
Dec 28, 2025 168.98 Bn
Sep 28, 2025 -15.24 Bn
Jun 29, 2025 -14.31 Bn
Mar 30, 2025 162.64 Bn
Dec 29, 2024 155.79 Bn
Sep 29, 2024 -12.52 Bn
Jun 30, 2024 -11.25 Bn
Mar 31, 2024 153.38 Bn
Dec 31, 2023 -12.53 Bn
Oct 1, 2023 152.54 Bn
Jul 2, 2023 129.38 Bn
Apr 2, 2023 124.56 Bn
Jan 1, 2023 128.35 Bn
Oct 2, 2022 -15.29 Bn
Jul 3, 2022 -13.84 Bn
Apr 3, 2022 124.38 Bn
Jan 2, 2022 -13.06 Bn
Oct 3, 2021 -15.42 Bn
Jul 4, 2021 120.15 Bn